HELP
HELP
NASDAQ · Pharmaceuticals

Cybin Inc

$4.75
+0.24 (+5.32%)
As of Mar 25, 6:10 PM ET ·
Financial Highlights (FY 2025)
Revenue
493.3K
Net Income
115.4K
Gross Margin
55.7%
Profit Margin
23.4%
Rev Growth
+17.7%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 55.7% 55.7% 55.7%
Operating Margin 26.4% 27.0% 27.8%
Profit Margin 23.4% 16.8% 21.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 493.3K 481.3K 473.6K
Gross Profit 274.9K 268.3K 264.0K
Operating Income 130.1K 130.0K 131.5K
Net Income 115.4K 80.6K 101.2K
Gross Margin 55.7% 55.7% 55.7%
Operating Margin 26.4% 27.0% 27.8%
Profit Margin 23.4% 16.8% 21.4%
Rev Growth +17.7% -1.9% +10.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 171.8K 222.1K 176.9K
Total Equity 1.50M 1.44M 1.63M
D/E Ratio 0.11 0.15 0.11
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 189.6K 155.0K 161.9K
Free Cash Flow 102.8K 100.3K 125.4K